Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elisabetta Patorno, Dr.P.H., M.D.

Co-Author

This page shows the publications co-authored by Elisabetta Patorno and Jessica Franklin.
Connection Strength

3.327
  1. Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride. Diabetes Care. 2019 12; 42(12):2204-2210.
    View in: PubMed
    Score: 0.844
  2. Prevalence of Avoidable and Bias-Inflicting Methodological Pitfalls in Real-World Studies of Medication Safety and Effectiveness. Clin Pharmacol Ther. 2021 Jul 14.
    View in: PubMed
    Score: 0.243
  3. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative. Circulation. 2021 03 09; 143(10):1002-1013.
    View in: PubMed
    Score: 0.234
  4. Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States. JAMA Netw Open. 2020 12 01; 3(12):e2031647.
    View in: PubMed
    Score: 0.233
  5. Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2020 09 29; 19(1):154.
    View in: PubMed
    Score: 0.230
  6. The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care. Endocrinol Diabetes Metab. 2020 Jan; 3(1):e00103.
    View in: PubMed
    Score: 0.217
  7. Glucose-lowering medications and the risk of cancer: A methodological review of studies based on real-world data. Diabetes Obes Metab. 2019 09; 21(9):2029-2038.
    View in: PubMed
    Score: 0.210
  8. Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care. Circulation. 2019 06 18; 139(25):2822-2830.
    View in: PubMed
    Score: 0.208
  9. Changes in Outpatient Use of Antibiotics by Adults in the United States, 2006-2015. Drug Saf. 2018 12; 41(12):1333-1342.
    View in: PubMed
    Score: 0.203
  10. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records. Diabetes Obes Metab. 2018 04; 20(4):974-984.
    View in: PubMed
    Score: 0.191
  11. Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases. Epidemiology. 2017 03; 28(2):237-248.
    View in: PubMed
    Score: 0.180
  12. How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools. BMJ Open. 2021 03 24; 11(3):e043961.
    View in: PubMed
    Score: 0.060
  13. Identifying Risk Factors for Diabetic Ketoacidosis Associated with SGLT2 Inhibitors: a Nationwide Cohort Study in the USA. J Gen Intern Med. 2021 09; 36(9):2601-2607.
    View in: PubMed
    Score: 0.059
  14. Postoperative inpatient utilization of opioid and opioid-sparing analgesics in the United States hospitals, 2007-2017. Pharmacoepidemiol Drug Saf. 2021 03; 30(3):390-394.
    View in: PubMed
    Score: 0.059
  15. Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions. J Gen Intern Med. 2019 11; 34(11):2339-2341.
    View in: PubMed
    Score: 0.054
  16. Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study. Am J Epidemiol. 2019 03 01; 188(3):609-616.
    View in: PubMed
    Score: 0.052
  17. Days' Supply of Initial Opioid Analgesic Prescriptions and Additional Fills for Acute Pain Conditions Treated in the Primary Care Setting - United States, 2014. MMWR Morb Mortal Wkly Rep. 2019 Feb 15; 68(6):140-143.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.